نتایج جستجو برای: 015 gr doses of nanoparticles

تعداد نتایج: 21184069  

Journal: :Cancer research 2000
J Nemunaitis I Ganly F Khuri J Arseneau J Kuhn T McCarty S Landers P Maples L Romel B Randlev T Reid S Kaye D Kirn

ONYX-015 is an E1B-55kDa gene-deleted adenovirus engineered to selectively replicate in and lyse p53-deficient cancer cells. To evaluate the selectivity of ONYX-015 replication and cytopathic effects for the first time in humans, we carried out a Phase II clinical testing of intratumoral and peritumoral ONYX-015 injection in 37 patients with recurrent head and neck carcinoma. Patients received ...

Objective(s): Evaluation of nanomaterials interaction with blood ingredients is a part of preclinical risk assessment of newly-synthesized materials, especially for nano-sized pharmaceuticals which are intravenously administrated. The red blood cells (RBCs) are susceptible to oxidative stress damage. This study was designed to evaluate induced oxidative hematotoxic effect of na...

2016
Xiaochuan Liu Aoli Wang Xiaofei Liang Cheng Chen Juanjuan Liu Zheng Zhao Hong Wu Yuanxin Deng Li Wang Beilei Wang Jiaxin Wu Feiyang Liu Stacey M. Fernandes Sophia Adamia Richard M. Stone Ilene A. Galinsky Jennifer R. Brown James D. Griffin Shanchun Zhang Teckpeng Loh Xin Zhang Wenchao Wang Ellen L. Weisberg Jing Liu Qingsong Liu

PI3Kδ is predominately expressed in leukocytes and has been found overexpressed in B-cell related malignances such as CLL and AML. We have discovered a highly selective ATP competitive PI3Kd inhibitor PI3KD-IN-015, which exhibits a high selectivity among other PI3K isoforms in both biochemical assays and cellular assay, meanwhile did not inhibit most of other protein kinases in the kinome. PI3K...

Journal: :Cancer research 2000
K R Rogulski S O Freytag K Zhang J D Gilbert D L Paielli J H Kim C C Heise D H Kirn

The E1B-deleted, replication-competent ONYX-015 (dl1520) adenovirus was originally described as being able to selectively kill p53-deficient cells due to a requirement of p53 inactivation for efficient viral replication. This hypothesis has become controversial because subsequent in vitro studies have demonstrated that the host range specificity of ONYX-015 is independent of p53 gene status. Us...

Journal: :Antimicrobial agents and chemotherapy 2013
Edurne Imbuluzqueta Carlos Gamazo Hugo Lana Miguel Ángel Campanero David Salas Ana Gloria Gil Elisa Elizondo Nora Ventosa Jaume Veciana María J Blanco-Prieto

The clinical management of human brucellosis is still challenging and demands in vitro active antibiotics capable of targeting the pathogen-harboring intracellular compartments. A sustained release of the antibiotic at the site of infection would make it possible to reduce the number of required doses and thus the treatment-associated toxicity. In this study, a hydrophobically modified gentamic...

Journal: :The Analyst 2014
Donghyuk Kim Solaire Finkenstaedt-Quinn Katie R Hurley Joseph T Buchman Christy L Haynes

Mesoporous silica nanoparticles are promising drug delivery agents; however, their interaction with various in vivo biological components is still under investigation. In this work, the impact of sub-50 nm diameter mesoporous silica nanoparticles on platelet function is investigated using a microfluidic platform to model blood vessel characteristics. Platelet adhesion and aggregation in the pre...

Journal: :The Journal of clinical endocrinology and metabolism 2002
Giuseppe Portella Stefania Scala Donata Vitagliano Giancarlo Vecchio Alfredo Fusco

Being one of the most lethal human neoplasms and refractory to such conventional treatment as chemo- and radiotherapy, anaplastic thyroid carcinoma is a prime target for innovative therapy. p53 gene inactivation is a constant feature of this neoplasia. Therefore, we evaluated a therapeutic approach based on an E1B 55-kDa gene-defective adenovirus (ONYX-015) that replicates only in cells with im...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Jeremy D Heidel Zhongping Yu Joanna Yi-Ching Liu Shyam M Rele Yongchao Liang Ryan K Zeidan Douglas J Kornbrust Mark E Davis

The results of administering escalating, i.v. doses of targeted nanoparticles containing a siRNA targeting the M2 subunit of ribonucleotide reductase to non-human primates are reported. The nanoparticles consist of a synthetic delivery system that uses a linear, cyclodextrin-containing polycation, transferrin (Tf) protein targeting ligand, and siRNA. When administered to cynomolgus monkeys at d...

Journal: :Cancer cell 2005
Clodagh C O'Shea Conrado Soria Bridget Bagus Frank McCormick

ONYX-015 is an E1B-55K-deleted adenovirus that has promising clinical activity as a cancer therapy. However, many tumor cells fail to support ONYX-015 oncolytic replication. E1B-55K functions include p53 degradation, RNA export, and host protein shutoff. Here, we show that resistant tumor cell lines fail to provide the RNA export functions of E1B-55K necessary for ONYX-015 replication; viral 10...

2014
Ajay Palagani Ken Op de Beeck Stefan Naulaerts Jolien Diddens Chandra Sekhar Chirumamilla Guy Van Camp Kris Laukens Karen Heyninck Sarah Gerlo Pieter Mestdagh Joke Vandesompele Wim Vanden Berghe

Glucocorticoids (GCs) selectively trigger cell death in the multiple myeloma cell line MM1S which express NR3C1/Glucocorticoid Receptor (GR) protein, but fail to kill MM1R cells which lack GR protein. Given recent demonstrations of altered microRNA profiles in a diverse range of haematological malignancies and drug resistance, we characterized GC inducible mRNA and microRNA transcription profil...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید